RxDoctor Payments Data

Andrew Soloway, MD

Psychiatry · Chester, PANPI 1467523753

Payments from drug & device makers

$779in general payments, 2019–2025

Across 40 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$172
  • Lundbeck LLC$135
  • Neurocrine Biosciences, Inc.$85
  • Johnson & Johnson$67
  • Teva Pharmaceuticals USA, Inc.$64
  • Sunovion Pharmaceuticals Inc.$57
  • plus $199 from 6 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$779 in reported general payments places this provider in the 70th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$71,215
Medicare patients
76
Services billed
864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole25$32,332
VraylarCariprazine Hcl16$24,818
Clozapine189$11,864
Aripiprazole85$11,337
Clomipramine Hcl27$10,923
Divalproex Sodium ErDivalproex Sodium89$7,735
Chlorpromazine Hcl32$7,633
AdderallDextroamphetamine/Amphetamine12$7,597
Oxcarbazepine73$5,786
Olanzapine154$4,156
Quetiapine Fumarate120$4,002
Divalproex Sodium90$3,370
Carbamazepine ErCarbamazepine19$3,056
Lurasidone Hcl14$3,003
Risperidone183$2,882

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$172$32,33225 claims
AbbVieVraylar$57$24,81816 claims
Takeda Pharmaceuticals U.S.A., Inc.Adderall$32$7,59712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →